Remove Correspondence Remove Creativity Remove Pharmaceutical
article thumbnail

In Brain Chemistry We Trust—The Gospel According to Pharma

Mad in America

Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.

article thumbnail

Two Decades of PSSD: A Life Stolen by Antidepressants

Mad in America

Once again, a pharmaceutical had altered an essential part of my body. My creativity vanished, the one thing I held sacred that in many ways had defined who I was. Countless supplements and over 30 different pharmaceuticals, I pretty much tried it all. I started freaking out. I got insomnia and could barely sleep.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

Mad in America

Consequently, there are three, and exactly three, basic forms of madness, and each form corresponds to a breakdown in one of the three faculties.” Moore: And of course, it was an open door then for the pharmaceutical industry, wasn’t it, with their massive marketing dollars. They’re not just tranquilizers.

article thumbnail

Much of U.S. Healthcare Is Broken: How to Fix It (Chapter 2, Part 6)

Mad in America

If one reads the ADM literature, it is quite apparent that the pharmaceutical industry—with the help of psychiatry—since day one has been involved in a cover up of the dangerousness of these drugs. of the drugs reviewed had two or fewer cases of violence, which is reassuring for most pharmaceuticals.

article thumbnail

Introducing the SUCCESS 125

Success

CEO, founder, creative strategist. Leigh Burgess is a creative strategist who uses her gifts to help others. As a designer, creative leader and strategist, she does not believe in simply running a company, but places more value on fostering relationships, growth and opportunity for her team and clients alike. Leigh Burgess.

article thumbnail

The next innovation revolution—powered by AI

McKensey

“Diagnosing the decline in pharmaceutical R&D efficiency,” 2012, Nature Reviews Drug Discovery , Volume 11, Number 3. Provocatively framed, AI can be more creative than humans. Leading companies in the pharmaceutical industry have already been deploying AI in their R&D processes. Scannell et al.,

Computer 111